About Idifarma
Idifarma is a Healthcare company based in Pamplona (Spain) founded in 2001, and was acquired by Ardena in September 2021. Drugs are developed and manufactured in various dosage forms. Idifarma offers products and services including Drug Substance Services, Drug Product Services, Bioanalysis Services, and CMC Regulatory Support. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is Ardena Holding NV.
Company details
Idifarma was founded in 2001 in Pamplona, Spain, as a pharmaceutical laboratory serving the pharmaceutical and biotechnological sectors. Services are offered in galenic, formulation, and analytical development, along with quality control, lot release, and GMP manufacturing for trial and industrial lots. Stability studies, clinical trial logistics, and regulatory assessments are also conducted to support drug production and market entry.
- Headquarters Pamplona, Spain
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website idifarma.com
- Social LinkedIn X
- Acquired by Ardena (Sep 2021)
- Legal Name Ardena Holding Nv
Products & Services of Idifarma
Idifarma offers a comprehensive portfolio of products and services, including Drug Substance Services, Drug Product Services, Bioanalysis Services, and CMC Regulatory Support.
Provides process development and manufacturing for drug substances.
Offers formulation development and GMP manufacturing.
Conducts mass spectrometry and immunochemistry for clinical trials.
Assists with report writing and regulatory submissions.
Funding Insights of Idifarma
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Idifarma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | Series B | – | – |
2 investors in total: 2 institutional.
Investors in Idifarma
Idifarma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Suanfarma and Ardena.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Generics, nutraceuticals, and APIs are developed by Suanfarma. | 1993 | suanfarma.com | Madrid, Spain | |
CDMO offering formulation development and solid state services for drug development | 2017 | ardena.com | Frankfurt Am Main, Germany |
Investor details for Idifarma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Idifarma
1 people are tracked at Idifarma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Luis Oquinena | Partner | Leadership |
Complete people profiles for Idifarma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Idifarma
3 dated milestones of Idifarma across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Idifarma is founded.
- Funding First funding round.
- Exit Acquired by Ardena.
Web traffic of Idifarma
Websites that share an audience with Idifarma (idifarma.com).
Websites whose visitors overlap most with Idifarma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
asenmco.info | asenmco.info | 100% | – | ||
| domainex.co.uk | 99% | 8.6K | #2,858,284 | View details | |
| molprofiles.co.uk | 86% | View details | |||
| pharm-int.com | 86% | 6.3K | #2,825,984 | View details | |
| bioreliance.com | 86% | 2.1K | #7,984,772 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Idifarma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Idifarma
Complete news archive for Idifarma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Idifarma
Idifarma was founded in 2001 and raised its 1st funding round 15 years after it was founded.
Idifarma is headquartered in Pamplona, Spain. It is registered at Pamplona, Navarra, Spain.
Idifarma was founded in 2001 in Pamplona, Spain, as a pharmaceutical laboratory serving the pharmaceutical and biotechnological sectors. Services are offered in galenic, formulation, and analytical development, along with quality control, lot release, and GMP manufacturing for trial and industrial lots. Stability studies, clinical trial logistics, and regulatory assessments are also conducted to support drug production and market entry.
Idifarma offers Drug Substance Services, Drug Product Services, Bioanalysis Services, and CMC Regulatory Support.
Idifarma operates through Ardena Holding Nv.
Yes. Idifarma was acquired by Ardena in September 2021.